David Mongan reports on a recent trial of omega-3 supplementation for the prevention of psychosis in people at ultra-high risk, which finds no evidence of a positive effect. He reflects on these findings and considers what’s next for the field.
[read the full story...]
Alison Clarke and Jo Robinson review a Finnish cohort study which suggests that hospital presentations for self-harm represent a clear opportunity for the identification and subsequent treatment of psychosis and bipolar disorder.
[read the full story...]
Georgie Buswell summarises a cross-sectional study, which used open questions to try and understand people’s lived experiences of taking antipsychotic drugs.
[read the full story...]
